Nuvation Bio Inc. Class A Common Stock vs YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $4.95 (market cap $1.71B), while YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF trades at $39.54 (market cap $28.90M). The key difference: Nuvation Bio Inc. Class A Common Stock is far larger — about 59.2× YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF's market cap, and YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF is more actively traded (22,657 versus 5,448,712). Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 0 Days and YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF for 60 Days on average.
| NUVB | QDTY | |
|---|---|---|
Market Cap | $1.71B | $28.90M |
Volume | 5,448,712 | 22,657 |
Sector | Health | Income / Options Overlay |
52-Week High | $9.54 | $46.71 |
52-Week Low | $3.41 | $36.57 |
Typical Hold Time | 0 Days | 60 Days |
Enterprise Value | $1.30B | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →QDTY is an actively managed ETF that employs a synthetic covered call strategy on the Nasdaq-100 Index using zero-days-to-expiration (0DTE) options. It aims to generate high weekly income by selling daily call options, providing limited participation in the index's upside while remaining fully exposed to its downside risk.
Read more on QDTY →